| Product Code: ETC13261149 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Infectious Disease Drug Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Infectious Disease Drug Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Infectious Disease Drug Market Revenues & Volume, 2021 & 2031F |
3.3 North America Infectious Disease Drug Market - Industry Life Cycle |
3.4 North America Infectious Disease Drug Market - Porter's Five Forces |
3.5 North America Infectious Disease Drug Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Infectious Disease Drug Market Revenues & Volume Share, By Source Type, 2021 & 2031F |
3.7 North America Infectious Disease Drug Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 North America Infectious Disease Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 North America Infectious Disease Drug Market Revenues & Volume Share, By Mode of Action Type, 2021 & 2031F |
3.10 North America Infectious Disease Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.11 North America Infectious Disease Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.12 North America Infectious Disease Drug Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 North America Infectious Disease Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Infectious Disease Drug Market Trends |
6 North America Infectious Disease Drug Market, 2021 - 2031 |
6.1 North America Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Infectious Disease Drug Market, Revenues & Volume, By Bacterial Diseases, 2021 - 2031 |
6.1.3 North America Infectious Disease Drug Market, Revenues & Volume, By Virusal Diseases, 2021 - 2031 |
6.1.4 North America Infectious Disease Drug Market, Revenues & Volume, By Fungal Disease, 2021 - 2031 |
6.1.5 North America Infectious Disease Drug Market, Revenues & Volume, By Parasitic Disease, 2021 - 2031 |
6.2 North America Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Infectious Disease Drug Market, Revenues & Volume, By Jaundice, 2021 - 2031 |
6.2.3 North America Infectious Disease Drug Market, Revenues & Volume, By Leprosy, 2021 - 2031 |
6.2.4 North America Infectious Disease Drug Market, Revenues & Volume, By Listeria, 2021 - 2031 |
6.2.5 North America Infectious Disease Drug Market, Revenues & Volume, By Lyme Disease, 2021 - 2031 |
6.2.6 North America Infectious Disease Drug Market, Revenues & Volume, By Malaria, 2021 - 2031 |
6.2.7 North America Infectious Disease Drug Market, Revenues & Volume, By Measles, 2021 - 2031 |
6.2.8 North America Infectious Disease Drug Market, Revenues & Volume, By Molluscum Contagiosum, 2021 - 2031 |
6.2.9 North America Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Infectious Disease Drug Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.3.3 North America Infectious Disease Drug Market, Revenues & Volume, By Dietary Supplements, 2021 - 2031 |
6.3.4 North America Infectious Disease Drug Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.4 North America Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Infectious Disease Drug Market, Revenues & Volume, By Antibacterial Drugs, 2021 - 2031 |
6.4.3 North America Infectious Disease Drug Market, Revenues & Volume, By Antiviral Drugs, 2021 - 2031 |
6.4.4 North America Infectious Disease Drug Market, Revenues & Volume, By Antifungal Drugs, 2021 - 2031 |
6.4.5 North America Infectious Disease Drug Market, Revenues & Volume, By Antiparasitic Drugs, 2021 - 2031 |
6.5 North America Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Infectious Disease Drug Market, Revenues & Volume, By Tafenoquine, 2021 - 2031 |
6.5.3 North America Infectious Disease Drug Market, Revenues & Volume, By Omadacycline, 2021 - 2031 |
6.5.4 North America Infectious Disease Drug Market, Revenues & Volume, By Tecovirimat, 2021 - 2031 |
6.5.5 North America Infectious Disease Drug Market, Revenues & Volume, By Eravacycline, 2021 - 2031 |
6.5.6 North America Infectious Disease Drug Market, Revenues & Volume, By Delafloxacin, 2021 - 2031 |
6.5.7 North America Infectious Disease Drug Market, Revenues & Volume, By Plazomicin, 2021 - 2031 |
6.5.8 North America Infectious Disease Drug Market, Revenues & Volume, By Benznidazole, 2021 - 2031 |
6.5.9 North America Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Infectious Disease Drug Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.6.3 North America Infectious Disease Drug Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.6.4 North America Infectious Disease Drug Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.7 North America Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Infectious Disease Drug Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.7.3 North America Infectious Disease Drug Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.7.4 North America Infectious Disease Drug Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.7.5 North America Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Infectious Disease Drug Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.1 United States (US) Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.2 Canada Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.3 Rest of North America Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.3 North America Infectious Disease Drug Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
7.3.1 United States (US) Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.2 Canada Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.3 Rest of North America Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 North America Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.1 United States (US) Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.2 Canada Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.3 Rest of North America Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5 North America Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.1 United States (US) Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.2 Canada Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.3 Rest of North America Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.6 North America Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.1 United States (US) Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.2 Canada Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.3 Rest of North America Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.7 North America Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.1 United States (US) Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.2 Canada Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.3 Rest of North America Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8 North America Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.1 United States (US) Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.2 Canada Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.3 Rest of North America Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 North America Infectious Disease Drug Market Key Performance Indicators |
9 North America Infectious Disease Drug Market - Export/Import By Countries Assessment |
10 North America Infectious Disease Drug Market - Opportunity Assessment |
10.1 North America Infectious Disease Drug Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Infectious Disease Drug Market Opportunity Assessment, By Source Type, 2021 & 2031F |
10.3 North America Infectious Disease Drug Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.4 North America Infectious Disease Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10.5 North America Infectious Disease Drug Market Opportunity Assessment, By Mode of Action Type, 2021 & 2031F |
10.6 North America Infectious Disease Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.7 North America Infectious Disease Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.8 North America Infectious Disease Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F |
11 North America Infectious Disease Drug Market - Competitive Landscape |
11.1 North America Infectious Disease Drug Market Revenue Share, By Companies, 2022 |
11.2 North America Infectious Disease Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here